Your browser doesn't support javascript.
loading
Sinonasal mucosal melanoma treatment response assessment to immune checkpoint inhibitors using hybrid positron emission tomography imaging.
Maurer, Alexander; Gstrein, Nathalie A; Dimitriou, Florentia; Sartoretti, Thomas; Schaab, Jan A; Looman, Esmée L; Balermpas, Panagiotis; Rupp, Niels J; Freiberger, Sandra N; Soyka, Michael B; Holzmann, David; Mauthe, Tina; Mueller, Simon A; Beintner-Skawran, Stephan; Messerli, Michael; Kenkel, David; Huellner, Martin W; Meerwein, Christian M.
Affiliation
  • Maurer A; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Gstrein NA; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.
  • Dimitriou F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Sartoretti T; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Schaab JA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Looman EL; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Balermpas P; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Rupp NJ; Department of Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Freiberger SN; Department of Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Soyka MB; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.
  • Holzmann D; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.
  • Mauthe T; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.
  • Mueller SA; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.
  • Beintner-Skawran S; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Messerli M; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Kenkel D; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Huellner MW; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Meerwein CM; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland. christian.meerwein@usz.ch.
Sci Rep ; 13(1): 18847, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37914764
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Paranasal Sinus Neoplasms / Melanoma Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Paranasal Sinus Neoplasms / Melanoma Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article